Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Myeloid-derived Suppressor Cells
100%
Tumor
30%
Interleukin-4 (IL-4)
30%
Interleukin-12 (IL-12)
24%
4-1BB
24%
Myeloid Cells
20%
Combination Therapy
20%
Tumor Immunity
18%
Leukocyte Immune-type Receptors
18%
Regulatory T (Treg) Cells
17%
Immune Tolerance
15%
In Cancer
15%
Cell Function
14%
CD8+ T Cells
14%
IL-4 Receptor
13%
Gene Delivery
12%
Signaling Pathway
12%
Immune Suppression
12%
Dendritic Cells
12%
Inositol Phosphatase
12%
Gr-1
12%
Immature Myeloid Cells
12%
Granulocyte Colony-stimulating Factor (G-CSF)
11%
Immunoreceptor Tyrosine-based Activation Motif
11%
Tumor Microenvironment
10%
LILRB2
10%
In Situ
10%
LILRB3
10%
Oncolytic Viral Therapy
10%
Tumor Immune Microenvironment
10%
Sympathetic Nervous System
10%
CAR T-cell Therapy
10%
Monocyte-derived Cells
10%
Immune Regulation
10%
Sunitinib
10%
Leukemia Progression
10%
Cancer Vaccine
10%
Like Receptors
10%
Acute Myeloid Leukemia
10%
Cancer Treatment
10%
Graft-versus-host Disease (GvHD)
10%
Tumor-bearing Mice
10%
Inhibitory Receptors
10%
Monocytic Myeloid-derived Suppressor Cells (M-MDSCs)
9%
Cell-to-cell
9%
Natural Killer Cells
9%
Tumor-specific
9%
Suppressive Function
9%
Cell-based
9%
Antitumor Effect
8%
Immunology and Microbiology
Myeloid-Derived Suppressor Cell
99%
Myeloid
45%
T Cell
42%
Regulatory T Cell
26%
Immunotherapy
26%
Dendritic Cell
19%
Cell Function
18%
Interleukin 4
18%
Cell Maturation
17%
Cytotoxic T-Cell
17%
Immune Tolerance
14%
Macrophage
14%
Tyrosine
13%
Tumor Vaccine
13%
Interleukin 12
12%
Gene Targeting
12%
Natural Killer Cell
12%
Intravenous Immunoglobulin
12%
Tumor Cell
11%
Colon
11%
Phosphatase
11%
Leukocyte Immunoglobulin-Like Receptors
11%
Immune Response
10%
LILRB2
10%
Sunitinib
10%
Neurological System
10%
Graft-Versus-Host Disease
10%
Immunocompetent Cell
9%
Immunoreceptor Tyrosine-Based Inhibitory Motif
9%
Granulocyte Macrophage Colony-Stimulating Factor
8%
Antigen Specificity
8%
Immunosuppressive Drug
8%
Autoimmune Disease
8%
Clonal Anergy
7%
Colorectal Carcinoma
7%
Antigen Presentation
7%
Gene Transfer
7%
Cell Activation
6%
CD8
6%
Virus
6%
T Cell Activation
6%
Antigen-Presenting Cell
6%
Wild Type
5%
Cell Infiltration
5%
In Vitro
5%
CD4
5%
Immunosuppression
5%
Porosity
5%
Recombination Signal Sequences
5%
Prostate
5%
Medicine and Dentistry
Neoplasm
35%
Receptor
32%
Myeloid Cell
30%
Myeloid-Derived Suppressor Cell
30%
Immunoglobulin
22%
Leukocyte
18%
Tumor
13%
Malignant Neoplasm
13%
Triple Negative Breast Cancer
10%
Tumor Immune Microenvironment
10%
Oncolytic Virotherapy
10%
Cell Maturation
10%
CAR T-cell therapy
10%
Acute Myeloid Leukemia
10%
Combination Therapy
10%
Breast Cancer
9%
Immunocompetent Cell
9%
T Cell
9%
Granulocyte Macrophage Colony Stimulating Factor
8%
Leukemia Cell
8%
Immunotherapy
8%
Leukemia
8%
Tumor Progression
7%
Clinical Trial
7%
Specific Tumor
7%
Cytotoxic T-Cell
7%
Interleukin 12
7%
Cell Function
6%
Gene Targeting
6%
Lung Cancer
6%
Immunological Tolerance
6%
Solid Malignant Neoplasm
6%
Interleukin 6
6%
Antigen Presenting Cell
6%
Non Small Cell Lung Cancer
6%
Immunology
6%
Diseases
6%
Hematologic Malignancy
6%
Cell Differentiation
5%
Graft Versus Host Reaction
5%
Graft Versus Leukemia Effect
5%
Cancer
5%
Ligation
5%
Revertant
5%
Tocilizumab
5%
N(g) Methylarginine
5%
Metastatic Colon Cancer
5%
Stem Cell Factor
5%
Stereotactic Body Radiation Therapy
5%
Pembrolizumab
5%
